Get Ready, Conditional Adult-Use Retail Dispensaries! Conditional Adult-Use Retail Licensees will be the first dispensaries to open for adult-use cannabis sales in New York State. Taking bold Browse CBD oil news, research and analysis from The Conversation
Get Ready, Conditional Adult-Use Retail Dispensaries!
Conditional Adult-Use Retail Licensees will be the first dispensaries to open for adult-use cannabis sales in New York State.
Taking bold actions to encourage social justice, public health and economic development in the lives of all New Yorkers
The Marijuana Regulation and Taxation Act creates a first in the nation comprehensive regulatory structure to oversee the licensure, cultivation, production, distribution, sale and taxation of medical, adult-use and cannabinoid hemp within New York State.
Establishes a robust social and economic equity program to actively encourage members from communities disproportionally impacted by the policies of prohibition to participate in the new industry.
Administers a sophisticated quality assurance regulatory structure including standards for production and manufacturing, strict product testing, labeling, packaging and advertising to ensure products are safe for consumers and not targeted to youth.
Encourages small business and farmers to participate in the cannabis industry with the creation of microbusiness, cooperative and delivery license types.
Articles on CBD oil
While licensed retailers are subject to inspections and constrained to selling products sourced through licensed channels, the unlicensed market seems to operate outside these requirements, with little pressure from law enforcement. (Shutterstock) May 3, 2022
Canada needs better CBD policies to protect consumers from unlicensed products
Majid Eghbali Zarch, Memorial University of Newfoundland; Jennifer Marlowe, Memorial University of Newfoundland, and Sandy Brennan, Memorial University of Newfoundland
Policy-makers and stakeholders in Canada should re-examine CBD policies and ensure they are protecting, rather than confusing, consumers.
It’s legal to buy over-the -counter cannabis in Australia – but it’s still a long way from your local chemist
Jennifer Martin, University of Newcastle and Catherine Lucas, University of Newcastle
The TGA gave low-dose cannabis sales without prescription the green light in February. But no product has jumped through all the regulatory hoops to market yet.
Why it’s time to treat medicinal cannabis as an alternative therapy, not a pharmaceutical
Non-intoxicating cannabis products are safe and well tolerated by those who use them, so why not lower the clinical threshold for their manufacture and sale?
CBD, made from hemp, is being hyped as treatment for pain, nausea and a variety of maladies. But studies so far do not show benefit in humans. ElRoi/Shutterstock.com January 30, 2019
CBD: Rising star or popular fad?
Jenny Wilkerson, University of Florida and Lance McMahon, University of Florida
Cannabidiol, or CBD, is being touted in popular culture as a miracle cure-all. From creams to gummies and more, CBD has exploded onto the health scene. But what does the science actually say?
A depiction of a cannabis bud drops from the ceiling at Leafly’s countdown party in Toronto as midnight passes and marks the first day of the legalization of cannabis across Canada. (Chris Young/The Canadian Press) January 24, 2019
Where’s the weed? Clues to Canada’s cannabis shortages
Government data suggest medical cannabis availability improved after legalization in Canada. But producers have struggled to meet demand for recreational cannabis other than oils.